Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients

ClinicalTrials.gov ID: NCT00225732

Public ClinicalTrials.gov record NCT00225732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery

Study identification

NCT ID
NCT00225732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cumberland Pharmaceuticals
Industry
Enrollment
319 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Jan 2008 (Actual)
Completion
Jan 2008 (Actual)
Last update posted
Jun 22, 2016

2005 – 2008

United States locations

U.S. sites
12
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Cooper Green Hospital / Jefferson Clinic Birmingham Alabama 35233 —
Medical Center East / Alabama Clinical Therapeutics Birmingham Alabama 35235 —
Springhill Hospital / Wilmax Clinical Research, Inc. Mobile Alabama 36608 —
Mobile Infirmary Medical Center / Wilmax Clinical Research, Inc. Mobile Alabama 36652-2144 —
Jackson Hospital / Drug Research and Analysis Corporation Montgomery Alabama 36106 —
Baptist Medical Center South / Drug Research and Analysis Corporation Montgomery Alabama 36111 —
Arizona Research Center Phoenix Arizona 85023 —
Valley OB/GYN Colton California 92324 —
Research Support Personnel LLC Wichita Kansas 67208 —
Chandler Medical Center; Ken Muse Research Lexington Kentucky 40536 —
Comprehensive Pain Specialists Hendersonville Tennessee 37075 —
Health First Medical Group Fort Worth Texas 76135 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00225732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2016 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00225732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →